Clear cell renal cell carcinoma with borderline features of clear cell papillary renal cell carcinoma combined morphologic, immunohistochemical, and cytogenetic analysis

American Journal of Surgical Pathology

Volumn 39, Issue 11, 2015, Pages 1502-1510

  Williamson, Sean R ^a   Gupta, Nilesh S ^a   Eble, John N ^c   Rogers, Craig G ^b   Michalowski, Susan ^a   Zhang, Shaobo ^c   Wang, Mingsheng ^c   Grignon, David J ^c   Cheng, Liang ^c  

^a HENRY FORD HOSPITAL   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chromosome 3p; Clear cell papillary renal cell carcinoma; Clear cell renal cell carcinoma; Cytogenetics; Intratumoral heterogeneity; Von hippel lindau

Indexed keywords

TUMOR MARKER;

ADULT; AGED; BIOPSY; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; CHEMISTRY; CHROMOSOME ANALYSIS; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KARYOTYPING; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTICENTER STUDY; NEOPLASMS, COMPLEX AND MIXED; PATHOLOGY; PREDICTIVE VALUE; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; BIOPSY; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; CYTOGENETIC ANALYSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INDIANA; KARYOTYPING; KIDNEY NEOPLASMS; MALE; MICHIGAN; MIDDLE AGED; NEOPLASMS, COMPLEX AND MIXED; PREDICTIVE VALUE OF TESTS;

EID: 84944062715     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000514     Document Type: Article

References (35)

1. Tickoo SK, de Peralta-Venturina MN, Harik LR, et al. Spectrum of epithelial neoplasms in end-stage renal disease: An experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol. 2006;30:141-153.
2. Gobbo S, Eble JN, Grignon DJ, et al. Clear cell papillary renal cell carcinoma: A distinct histopathologic and molecular genetic entity. Am J Surg Pathol. 2008;32:1239-1245.
3. Zhou H, Zheng S, Truong LD, et al. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma. Hum Pathol. 2014;45:59-64.
4. Alexiev BA, Drachenberg CB. Clear cell papillary renal cell carcinoma: Incidence, morphological features, immunohistochemical profile, and biologic behavior: A single institution study. Pathol Res Pract. 2014;210:234-241.
5. Williamson SR, Eble JN, Cheng L, et al. Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile. Mod Pathol. 2013;26:697-708.
6. Aydin H, Chen L, Cheng L, et al. Clear cell tubulopapillary renal cell carcinoma: A study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol. 2010;34:1608-1621.
7. Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol. 2013;37:1469-1489.
8. Rohan SM, Xiao Y, Liang Y, et al. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod Pathol. 2011;24:1207-1220.
9. Adam J, Couturier J, Molinie V, et al. Clear-cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases. Histopathology. 2011;58:1064-1071.
10. Bhatnagar R, Alexiev BA. Renal-cell carcinomas in end-stage kidneys: A clinicopathological study with emphasis on clear-cell papillary renal-cell carcinoma and acquired cystic kidney diseaseassociated carcinoma. Int J Surg Pathol. 2012;20:19-28.
11. Inoue T, Matsuura K, Yoshimoto T, et al. Genomic profiling of renal cell carcinoma in patients with end-stage renal disease. Cancer Sci. 2012;103:569-576.
12. Wolfe A, Dobin SM, Grossmann P, et al. Clonal trisomies 7, 10 and 12, normal 3p and absence of VHL gene mutation in a clear cell tubulopapillary carcinoma of the kidney. Virchows Arch. 2011;459:457-463.
13. Kuroda N, Shiotsu T, Kawada C, et al. Clear cell papillary renal cell carcinoma and clear cell renal cell carcinoma arising in acquired cystic disease of the kidney: An immunohistochemical and genetic study. Ann Diagn Pathol. 2011;15:282-285.
14. Munari E, Marchionni L, Chitre A, et al. Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma. Hum Pathol. 2014;45:1130-1138.
15. Fisher KE, Yin-Goen Q, Alexis D, et al. Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma. Mod Pathol. 2014;27:222-230.
16. Williamson SR, Zhang S, Eble JN, et al. Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma. Am J Surg Pathol. 2013;37:1131-1139.
17. Chen YB, Tickoo SK. Spectrum of preneoplastic and neoplastic cystic lesions of the kidney. Arch Pathol Lab Med. 2012;136: 400-409.
18. Gobbo S, Eble JN, MacLennan GT, et al. Renal cell carcinomas with papillary architecture and clear cell components: The utility of immunohistochemical and cytogenetical analyses in differential diagnosis. Am J Surg Pathol. 2008;32:1780-1786.
19. Cheng L, MacLennan GT, Zhang S, et al. Evidence for polyclonal origin of multifocal clear cell renal cell carcinoma. Clin Cancer Res. 2008;14:8087-8093.
20. Cossu-Rocca P, Eble JN, Delahunt B, et al. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma. Mod Pathol. 2006;19:488-493.
21. Jones TD, Eble JN, Wang M, et al. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Clin Cancer Res. 2005;11:7226-7233.
22. Weller M, Berger H, Hartmann C, et al. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker? Clin Cancer Res. 2007;13:6933-6937.
23. Wiens AL, Cheng L, Bertsch EC, et al. Polysomy of chromosomes 1 and/or 19 is common and associated with less favorable clinical outcome in oligodendrogliomas: Fluorescent in situ hybridization analysis of 84 consecutive cases. J Neuropathol Exp Neurol. 2012;71:618-624.
24. Brunelli M, Fiorentino M, Gobbo S, et al. Many facets of chromosome 3p cytogenetic findings in clear cell renal carcinoma: The need for agreement in assessment FISH analysis to avoid diagnostic errors. Histol Histopathol. 2011;26:1207-1213.
25. Delahunt B, Cheville JC, Martignoni G, et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. 2013;37:1490-1504.
26. Cheng L, Williamson SR, Zhang S, et al. Understanding the molecular genetics of renal cell neoplasia: Implications for diagnosis, prognosis and therapy. Expert Rev Anticancer Ther. 2010;10:843-864.
27. Grignon DJ, Eble JN, Bonsib SM, et al. Clear cell renal cell carcinoma. In: Eble JN, Sauter G, Epstein JI, et al, eds. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press; 2004:23-25.
28. Reuter VE, Tickoo SK. Differential diagnosis of renal tumours with clear cell histology. Pathology. 2010;42:374-383.
29. Rao P, Monzon F, Jonasch E, et al. Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome- clinicopathological features and comparative genomic analysis of 3 cases. Hum Pathol. 2014;45:1966-1972.
30. Williamson SR, Cheng L. Do clear cell papillary renal cell carcinomas occur in patients with von Hippel-Lindau disease? Hum Pathol. 2015;46:340-341.
31. Rao P, Tamboli P. Do clear cell papillary renal cell carcinomas occur in patients with von Hippel-Lindau disease?-reply. Hum Pathol. 2015;46:341-343.
32. Petersson F, Grossmann P, Hora M, et al. Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma. Hum Pathol. 2013;44:1412-1420.
33. Klatte T, Said JW, Seligson DB, et al. Pathological, immunohistochemical and cytogenetic features of papillary renal cell carcinoma with clear cell features. J Urol. 2011;185:30-35.
34. Mertz KD, Demichelis F, Sboner A, et al. Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. Int J Cancer. 2008;123:569-576.
35. Mai KT, Kohler DM, Belanger EC, et al. Sporadic clear cell renal cell carcinoma with diffuse cytokeratin 7 immunoreactivity. Pathology. 2008;40:481-486.